Suninflam Epilepsy Purpose of the study? This is a dose escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SIF001, a monoclonal antibody with the potential to treat epilepsy. Detailed Description Nonclinical studies including disease animal model studies and toxicological studies indicate that SIF001 has the potential to be a therapeutic agent for […]
Suninflam Epilepsy Read More »
Xenon X-TOLE2/X-ACT/X-TOLE4 (Active, No longer Recruiting) About the study? About Study: The Xenon studies are investigating the effect of a novel anti-seizure medication, XEN1101, on seizure frequency for patients diagnosed with Focal or Generalized Epilepsy. Patients will take either the active study drug or the placebo, and have the option to enroll in a long-term
Xenon X-TOLE2/X-ACT/X-TOLE4 Read More »
Biohaven BHV7000 Rise Focal Epilepsy Study About the study? A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy. Purpose of the study? If you or a loved one have been diagnosed with focal onset epilepsy, are between the ages of
Biohaven BHV7000 Rise Read More »
Praxis Power2 study for Focal Epilepsy About the study? A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures. Purpose of the study? The main purpose of this research is to see how well vormatrigine works for treating focal onset seizures compared with placebo, as well as its
Praxis Power2 study Read More »
Supernus RENAISSANCE 2 Please see below for Epilepsy Research Opportunity. For more information please contact: Jacara WashingtonClinical Research CoordinatorP: 716-961-9220E: jawashington@dentinstitute.com
Supernus RENAISSANCE 2 Read More »
Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
STARS and STARS Extension Read More »
